| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |